What are the typical symptoms of alpha‑1 antitrypsin deficiency in a child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Symptoms of Alpha-1 Antitrypsin Deficiency in Children

Children with alpha-1 antitrypsin deficiency predominantly present with liver disease manifestations, most commonly appearing at 1-2 months of age with prolonged jaundice and hepatomegaly, though the clinical spectrum ranges from asymptomatic to severe liver failure. 1

Neonatal and Infant Presentations (Most Common)

The typical presentation in early infancy includes:

  • Prolonged jaundice with conjugated hyperbilirubinemia (elevated conjugated bilirubin)
  • Hepatomegaly (enlarged liver)
  • Elevated serum transaminases (liver enzymes) that may persist for years even when clinical signs resolve 1
  • Neonatal cholestasis syndrome - this is a key presentation that should trigger testing 1

Bleeding Manifestations

A critical early presentation involves coagulopathy from vitamin K deficiency, manifesting as:

  • Gastrointestinal bleeding
  • Bleeding from the umbilical stump
  • Easy bruising
  • Rarely, central nervous system hemorrhage

This bleeding diathesis requires immediate vitamin K supplementation, which can be life-saving 1

Growth and Development Issues

  • Failure to thrive with or without obvious liver disease 1
  • Mild hepatomegaly without other prominent symptoms
  • Poor feeding and poor growth 1

Progressive Disease in Infancy

A small proportion of affected infants develop:

  • Progressive hepatosplenomegaly (enlarged liver and spleen)
  • Ascites (fluid accumulation in abdomen)
  • Liver synthetic dysfunction
  • Fulminant hepatic failure (rare but documented) 1

Rare Presentations

  • Cholestatic pruritus with hypercholesterolemia and paucity of intrahepatic bile ducts 1

Later Childhood and Adolescent Presentations

Beyond infancy, children may present with:

  • Hepatosplenomegaly
  • Ascites
  • Upper gastrointestinal bleeding from esophageal varices
  • Chronic hepatitis
  • Cirrhosis
  • Hepatic failure 1

These presentations can mimic other chronic liver diseases including autoimmune hepatitis, drug-induced hepatitis, chronic viral hepatitis, and Wilson's disease 1

Respiratory Symptoms (Uncommon in Children)

While respiratory disease is the hallmark of adult AATD, pulmonary symptoms are rare in childhood:

  • Recurrent bronchitis with wheezing (reported in approximately 8% of PI*ZZ children in screening studies) 2
  • Persistent cough (typically in children with cirrhosis)
  • Severe pneumonia (rare)
  • Bronchial hyperreactivity 3

Most children with AATD do not have pulmonary symptoms, even those with severe deficiency 3, 2

Other Associated Findings

Less common manifestations reported include:

  • Pronounced eczema
  • Urinary tract infections
  • Congenital malformations 2

Clinical Variability and Key Pitfalls

The presentation is highly variable - ranging from completely asymptomatic children to severe, fatal liver failure 1. This variability is critical to recognize:

  • Many children remain asymptomatic despite having PI*ZZ genotype
  • Elevated transaminases may persist for years without clinical progression 1
  • Approximately 11% of PI*ZZ infants develop neonatal cholestasis, and about 3 of these will have cirrhosis by age 2 years 2
  • About 50% of asymptomatic PI*ZZ children have occasional elevated liver enzymes 2

Important Diagnostic Considerations

Testing should be performed in any infant with:

  • Conjugated hyperbilirubinemia
  • Elevated serum transaminases
  • Neonatal hepatitis syndrome
  • Any unexplained liver disease 1

Heterozygous children (PI*MZ) typically do not develop clinically significant liver disease in childhood, though enzyme levels may fluctuate 4. PI*SZ children generally have milder or no significant clinical liver disease 1, 2.

Prognostic Indicators

Poor prognosis is suggested by:

  • Neonatal cholestasis 1
  • Elevated transaminases, bilirubin, and prolonged prothrombin time 1
  • Hard hepatomegaly 1

First-degree family members of newly diagnosed patients should be tested, as many affected individuals are identified through family studies 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.